Hemorrhagic Age-Related Macular Degeneration Managed With Vitrectomy, Subretinal Injection of Tissue Plasminogen Activator, Gas Tamponade, and Upright Positioning

Basit Öğe Kaydı
dc.authorid0000-0002-1940-8669en_US
dc.contributor.authorKapran, Ziya
dc.contributor.authorOzkaya, Abdullah
dc.contributor.authorUyar, O. Murat
dc.date.accessioned2024-07-12T21:52:38Z
dc.date.available2024-07-12T21:52:38Z
dc.date.issued2013en_US
dc.departmentMaltepe Üniversitesien_US
dc.description.abstractBACKGROUND AND OBJECTIVE: To investigate the outcomes of vitrectomy, subretinal tissue plasminogen (tPA) injection, gas tamponade, and upright positioning in patients with hemorrhagic neovascular age-related macular degeneration (AMD). PATIENTS AND METHODS: Retrospective, noncomparative case series. Records of patients who were diagnosed with submacular hemorrhage secondary to neovascular AMD and underwent treatment with the combined method between 2004 and 2010 were reviewed. The main outcome measure was the difference between preoperative and postoperative best corrected visual acuity (BCVA). RESULTS: In 10 eyes of 10 patients, mean preoperative and postoperative BCVA values were 1.75 and 1.23 logMAR, respectively (P = .011), after a mean follow-up time of 38.7 +/- 26.5 months (range: 10 to 71 months). Eight of 10 patients (80%) gained at least three lines. CONCLUSION: In patients with hemorrhagic neovascular AMD, treatment with vitrectomy, subretinal tPA injection, gas tamponade, and upright positioning was associated with better visual outcomes than those reported for patients with untreated disease.en_US
dc.identifier.doi10.3928/23258160-20130909-09
dc.identifier.endpage476en_US
dc.identifier.issn1542-8877
dc.identifier.issn1938-2375
dc.identifier.issue5en_US
dc.identifier.pmid24044710en_US
dc.identifier.scopus2-s2.0-84884954440en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage471en_US
dc.identifier.urihttps://dx.doi.org/10.3928/23258160-20130909-09
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8413
dc.identifier.volume44en_US
dc.identifier.wosWOS:000330192400008en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSLACK INCen_US
dc.relation.ispartofOPHTHALMIC SURGERY LASERS & IMAGINGen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY03171
dc.titleHemorrhagic Age-Related Macular Degeneration Managed With Vitrectomy, Subretinal Injection of Tissue Plasminogen Activator, Gas Tamponade, and Upright Positioningen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu